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Abstract
Objective. The aim of this study was to develop a risk adjustment model for major adverse cardiac and cerebrovascular
events following percutaneous coronary intervention (PCI), using data from a national registry, and to highlight the use of the
risk adjustment when we evaluate the quality of care in interventional cardiology.
Design. The study design was based on a Coorte study. Bivariate and multivariate logistic regression models were used to
identify independent risk factors for these major adverse events.
Setting. A total of 19 hospitals from the Portuguese National Registry of Interventional Cardiology.
Participants. Data from 10.641 consecutives procedures collected between June 30, 2003 and June 30, 2006.
Intervention. Build a risk adjustment model for these major adverse events, following percutaneous coronary intervention.
Main Outcome Measure. Factors that were associated with major adverse cardiac and cerebrovascular events following
percutaneous coronary intervention.
Results. The rate of in-hospital major adverse cardiac and cerebrovascular events was 1.9%. Factors associated with major
adverse cardiac and cerebrovascular events included, among others: age .80 years (adjusted odds ratio ¼ 3.91); female
gender (1.72); and cardiogenic shock (6.05). Overall, a good discrimination was achieved with receiver operating characteristics
curve ¼ 0.84 and Hosmer-Lemeshow goodness of fit statistic across groups of risk was not significant (P ¼ 0.18) indicating
little departure from a perfect fit.
Conclusions. These findings will represent an important contribution to quality and safety improvement and should help
driving new research and innovative approaches to different subgroups of patients who have higher chances of having an
adverse event or poorer outcomes following this intervention.
Keywords: risk adjustment, PCI, quality improvement, safety, outcomes research
Introduction
The growing emphasis and interest in Quality are relatively
recent phenomena in health systems. In fact, it is a current
theme that has become particularly important in the agendas
and the policies of many countries all over the world [1, 2].
The concept of quality in health is nowadays seen from
different viewpoints and is defined in different ways. There
are several models to assess quality of care, each one with
different dimensions and approaches. The mostly used world-
wide is the model defined, some years ago, by Donabedian,
based on three dimensions: structure, process and outcomes
[3]. In the last years, particularly in the United States of
America, Canada, Australia, and some European countries,
the emphasis is increasingly on outcomes evaluation [4, 5].
The establishment of quality standards based on patient
outcome data is a rational means for differentiating the quality
of health care in the marketplace. However, variation in patient’s
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baseline clinical risks precludes the direct comparison of out-
comes across operators, institutions and health care plans.
Moreover, according to Iezzoni [6], meaningful comparison
within the health care system, generally requires risk adjustment
– accounting for patient associated factors before comparing
outcomes across different patients, treatments, providers, health
plans, or populations. The rationale is obvious; on an average
higher-risk patients typically generate larger costs, and persons
with complex illnesses, multiple coexisting diseases, or other
significant risk factors, generally develop more complications
and have poorer outcomes, even with excellent care.
There have been several attempts, in recent years, particularly
in the United States of America and Europe, to incorporate
risk-adjustment methodology in the evaluation of percutaneous
coronary intervention (PCI) outcomes [7–10]. These attempts
have been limited by small sample sizes, patient samples that do
not reflect contemporary PCI, limited geographic represen-
tation, inconsistent definitions and coding of the variables,
poor quality of the data used to build these models, and conse-
quently, by the lack of applied data standards.
In 2002, the Portuguese Society of Cardiology launched
the national registry on interventional cardiology, not a man-
datory registry like in Sweden, with the aim to obtain know-
ledge about the profile of the patient, patterns of disease
and treatment strategies; to assess adherence to guidelines of
cardiovascular disease in clinical practice; and to stimulate
clinical research in this important area [11].
Since 2005, the Portuguese registry uses the Euro Heart
Survey on PCI platform, which reinforce more the quality of
data [since it uses the Cardiology Audit and Registration
Data Standards system (CARDS)] and have opened a window
to future comparisons among European countries, which
used similar data [12].
Methods
Study population
Retrospective analysis of prospective collected data from 10 641
consecutive patients who underwent PCI, in a total of 19
Portuguese centres who participated in the Portuguese PCI
registry, between June 30, 2003 and June 30, 2006.
As a major adverse event, for the purpose of this study,
we considered a composite variable comprising, death, acute
myocardial infarction, need for a new revascularization by
urgent coronary artery bypass graft, and stroke.
We considered as independent variables those that charac-
terize the individuals and treatment aspects, namely demo-
graphic (e.g. age, gender); clinical aspects (e.g. diabetes,
hypertension, peripheral disease) and technical and functional
aspects (e.g. number of vessels diseased, lesion type, ejection
fraction, defined as normal .50%; slightly reduced 41–50%;
moderately reduced 31–40%; severely reduced ,30%).
Data collection
The data were collected from the PCI database of the
national centre of data collection in cardiology, the structure
of the Portuguese Society of Cardiology, which is responsible
for the Portuguese registry. The Portuguese database is based
on the Euro Heart Survey of the European Society of
Cardiology. Data collection methods and definition of the
variables follow the policy of CARDS system of European
Society of Cardiology. The form, for each procedure, is filled
in a web platform and the quality control of the data and
audit is done by European Society of Cardiology. After that,
the data are sent to the Portuguese national centre and then
distributed to each participant centres. Data are also available
in the webpage of the European Society of Cardiology.
Statistical analysis
Firstly, we have started with a descriptive analysis with the
aim to get knowledge about the population patterns with
respect to each variable.
Subsequently, a bivariate analysis was done crossing the
independent (those who characterize the individuals and
treatment aspects) with the dependent variable, with the aim
of identifying those that have the strongest statistical associ-
ation with major adverse cardiac and cerebrovascular events.
To build the model, and to identify independent risk
factors for major adverse cardiac and cerebrovascular events,
a multivariate logistic regression analysis was undertaken,
using the stepwise forward technique, which includes all
variables that showed, in the bivariate analysis, an odds ratio
.1 (which indicates a positive association for the occurrence
of major adverse cardiac and cerebrovascular events), and
were statistically significant (with P-value ,0.05).
To assess the performance and calibration of the model,
the area under the receiver operating characteristics (ROC)
curve and the Hosmer–Lemeshow goodness of fit statistic
were calculated.
All statistical analysis were conducted using the Statistical
programw SPSS 14, for a level of significance of 0.05
(P ¼ 0.05) and a confidence interval (CI) of 95%. The
association measure used was the odds ratio.
Results
In the 10 641 patients who underwent PCI, and were
included in the register, the primary success rate was 98.1%
and the rate of in-hospital major adverse cardiac and cere-
brovascular events was 1.9%. In these, 1.4% was death; 0.4%
developed an acute myocardial infarction; 0.2% had a stroke;
and 0.1% emergency coronary artery bypass graft. These
rates are not mutually exclusive, which means that in some
patients occurred more than one major adverse event.
The first step of the model development was to examine
the bivariate relationship between major adverse cardiac and
cerebrovascular events and each pre-procedural risk factor
(Table 1). In the multivariate logistic regression model we
included all the variables that showed, in the bivariate analy-
sis, an odds ratio .1 and were statistically significant (with
P-value ,0.05), such as age, gender, acute myocardial infarc-
tion, cardiogenic shock, congestive heart failure, diabetes,
peripheral disease, renal failure (creatinine .2.0 mg/dl),
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Table 1 Univariate and bivariate analysis between dependent and independent variables
Variable % of patients






Age ,50 years 13.7 1.0 Reference
Age 50–59 years 23.4 1.4 1.44 (0.75–2.75) 0.21
Age 60–69 years 30.8 1.4 1.51 (0.81–2.81) 0.20
Age 70–79 years 26.5 2.4 2.53 (1.39–4.61) 0.002
Age .80 years 5.6 7.1 7.85 (4.16–14.82) ,0.001
Gender
Male 24.9 1.6 1.79 (1.32–2.41) ,0.001
Female 75.1 2.9
Acute myocardial infarction
No 82.0 0.9 7.39 (5.50–9.91) ,0.001
Yes 18.0 6.6
Cardiogenic shock
No 99.1 1.5 62.46 (39.40–97.79) ,0.001
Yes 0.9 48.9
Myocardial infarction antecedents
No 65.4 2.0 0.81 (0.59–1.11) 0.19
Yes 34.6 1.7
Congestive heart failure
No 95.1 1.8 7.39 (5.50–9.91) ,0.001
Yes 4.9 3.8
Prior coronary artery bypass graft
No 95.2 1.9 1.23 (0.67–2.29) 0.51
Yes 4.8 2.3
Prior percutaneous coronary intervention
No 84.6 1.9 0.87 (0.58–1.33) 0.53
Yes 15.4 1.7
Prior cerebrovascular disease
No 97.1 1.9 1.70 (0.86–3.36) 0.12
Yes 2.9 3.1
Hypertension
No 36.2 1.8 1.07 (0.79–1.44) 0.68
Yes 63.8 1.9
Diabetes
No 74.7 1.7 1.42 (1.04–1.93) 0.03
Yes 25.3 2.4
Peripheral disease
No 97.1 1.8 2.96 (1.72–5.08) ,0.001
Yes 2.9 5.2
Renal failure
No 98.0 1.8 3.86 (2.16–6.91) ,0.001
Yes 2.0 6.6
Ejection fraction (normal) 71.9 1.0 Reference
Ejection fraction slightly reduced 18.2 1.5 1.55 (0.98–2.47) 0.06
Ejection fraction moderately reduced 6.2 2.7 2.78 (1.57–4.90) ,0.001
Ejection fraction severely reduced 3.7 10.1 11.43 (7.43–17.61) ,0.001
One vessel disease 50.6 1.3 Reference
Two vessels disease 31.3 1.9 1.40 (0.98–2.01) 0.06
Three or more vessels diseases 18.1 3.8 2.91 (2.06–4.11) ,0.001
Intra-aortic balloon pump
No 99.3 1.7 42.39 (25.18–71.24) ,0.001
Yes 0.7 42.2
(continued )
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ejection fraction, number of diseased vessels, intra-aortic
balloon pump, type of lesion, non-stenting, priority of pro-
cedure and left main treated.
In Table 2 we can see the variables that resulted from the
multivariate logistic regression analysis, using the stepwise
forward technique, with their respective coefficient, odds
ratio, significance value and CI.
Overall, a good discrimination was achieved with ROC
curve ¼ 0.84 (Fig. 1), and a Hosmer–Lemeshow goodness of
fit statistic across groups of risk was not significant (P ¼ 0.18),
indicating little departure from a perfect fit.
Discussion
In today’s world, the rapid spread of information, growing
level of knowledge and greater requirements of patients,
strong financial constraints, increasing call for accountability,
and the need to introduce criteria and quality indicators in
the health care provided, have contributed to some change in
the dynamics of health institutions [13, 14]
These dynamics have evolved in the direction of giving
greater value to the collection and treatment of credible stan-
dardized data which makes possible the evaluation and
monitor of services regarding the volume of activity and the
quality of results achieved [15].
The final goal of risk adjustment is to account for perti-
nent patient characteristics before making inference about
the effectiveness of care.
In the recent past we have seen great progress in PCI
that has led to a widening range of situations with well-
established clinical and angiographic indications [16–18].
However, PCI still carries significant risk, especially in
subgroups in which a more complex clinical condition may
lead to higher adverse event rates.
In Portugal, the number of procedures and centres where
PCI is performed has exponentially increased in the past
decade, from 3017 interventions (302 per million inhabitants)
in 12 centres, in 1997 [19] to an estimation of about 11 500
(1150 per million inhabitants) in 24 centres, in 2006.
With this rapid increase in the number of procedures and
centres which perform PCI in Portugal, which is similar to
the trend of other European countries, and since there is a
national continuous registry, it would be important to build a
risk-adjustment model. This could greatly help to do reliable
comparisons of results among institutions, regions or popu-
lations, contributing for the development of multicentre
studies, and establishing credible and rigorous benchmarking
values in the country.
Information obtained from registries is increasingly being
used to assess the process of care and patient outcomes, sup-
ported by the paradigm that the future of healthcare is
increasingly in the hands of those who are effective users of
clinical data [20].
Moreover, this brings up another important question that
Portugal and all European countries must face in the short
term – which is the need for reliable and standardized data
systems to collect, systematize and analyse data which could
help to monitor the health care system either, partially or as
a whole. For these have concurred different reasons such as:
(i) strong movements for accountability and pressing for
outcome data, due to the fact that the consumers of today
are more informed and demanding than ever, and call for a
description of the recommended treatment and its advan-
tages and risks [21]; (ii) legal questions, the example of
United Kingdom, since the introduction of freedom of
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 1 Continued
Variable % of patients






Lesion type A (American College of
Cardiology classification)
7.7 0.9 Reference
Lesion type B 60.0 1.4 1.45 (0.67–3.16) 0.35
Lesion type C 32.3 3.2 3.55 (1.64–7.67) ,0.001
Non-stenting
No 94.0 1.6 4.43 (3.09–6.34) ,0.001
Yes 6.0 6.7
Left main treated
No 99 1.8 6.00 (3.07–11.73) ,0.001
Yes 1.0 10.1
PCI in graft lesions
No 98.6 1.9 1.15 (0.36–3.63) 0.75
Yes 1.4 2.2
Priority of procedure (urgent/emergent)
No 72.0 0.8 6.70 (4.89–9.19) ,0.001
Yes 28.0 5.0
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information act, that became mandatory the individual dis-
closure information about the surgeons results, in different
areas [9]. We believe that any attempt to produce unadjusted
outcome analysis and comparisons, by named operator, or
institutions, may be misleading and will therefore encourage
adverse selection practices, and will jeopardize the relation-
ship between patients and health care professionals; (iii)
economic implications, which point out not only the import-
ance of effectiveness but also the efficiency of the health
care delivered [22].
It is well known that the absence of guidelines for data
collection and clear definitions of data items are very import-
ant causes of data errors in medical registries, making it
difficult to develop multicentre studies and also hampering
the comparisons of results between different regions and
countries [12, 15].
By developing and using data standards, based on the
CARDS system, the Euro Heart Survey and all registries that
use their platform, avert these questions and have greatly
expanded the pool of patients and geographical area in
which data outcomes can be analysed and compared [12].
Furthermore this emphasizes the importance of health
outcome analysis, based on credible, standardized and
audited data, as a central point in a quality assurance pro-
gramme and also as a key pathway in the direction of redu-
cing the burden of cardiovascular disease in Europe.[23, 24].
Bearing in mind that cardiovascular disease, including cor-
onary artery disease, affects millions of patients worldwide,
with serious consequences in economic and social weight,
evaluation of the results of PCI using credible information
and systematic databases is crucial for the achievement of
the greater objective which is to guarantee and improve the
quality of health care provided [17, 21, 24]. Therefore the
use of risk adjustment in outcomes evaluation for PCI is
essential to assess different quality dimensions such as effec-
tiveness, efficiency and safety [23, 25, 26].
There are multiple areas where the risk-adjustment method-
ology can be used to contribute to strengthen the quality
assessment and by this means reach the quality improvement,
including the following: to detect potential adverse selection
(based on the severity of the disease); to identify and define, in
a more rigorous way, quality indicators; for quality assessment
purposes, providing a comparison of outcomes among provi-
ders (hospitals or physicians) after adjusting for risk and asses-
sing changes in risk-adjusted outcomes for a single provider
over time; and to help explain and understand the impact of
practice variations among providers, and their implication in
different clinical and economic outcomes [6, 27].
The risk-adjustment model developed in this study, by
allowing the identification and evaluation of patient risk
factors that are associated with poor outcomes or adverse
events, constitutes a potential contribution to quality improve-
ment in interventional cardiology. However, it needs to be
tested in future prospective studies.
Generally, the models for risk adjustment are built based on
clinical data. However, it will be important, in the future, to
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 2 Independent risk factors for major adverse cardiac
and cerebrovascular events
Variable Coefficient Adjusted OR
(95% CI)
P-value
Age ,50 years 0.03 1.03 (0.47–2.29) 0.94
Age 50–59 years 0.09 1.10 (0.51–2.35) 0.81
Age 60–69 years 0.56 1.75 (0.84–3.64) 0.13
Age 70–79 years 1.36 3.91 (1.74–8.77) 0.001
Gender (female) 0.54 1.72 (1.13–2.61) 0.01
Acute myocardial
infarction
0.99 2.68 (1.46–4.93) 0.001
Cardiogenic shock 1.80 6.05 (2.44–15.01) ,0.001
Renal failure 1.09 2.98 (1.28–6.97) 0.01
Ejection fraction
slightly reduced




0.16 1.17 (0.60–2.27) 0.64
Ejection fraction
severely impaired
1.37 3.94 (2.22–7.01) ,0.001
Two vessels
disease
0.26 1.30 (0.81–2.09) 0.29
Three or more
vessels diseases
0.78 2.18 (1.35–3.51) 0.001
Lesion type B 0.48 1.62 (0.49–5.33) 0.43
Lesion type C 0.96 2.60 (0.79–8.61) 0.12
Intra-aortic
balloon pump
1.44 4.21 (1.53–11.56) 0.005




0.74 2.11 (1.13–3.91) 0.02
Constant 26.63 – –
Figure 1 Area under the receiver operating characteristics
(ROC) curve for multivariate prediction model
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include also economic data (costs per patient and per procedure,
or cross-data from diagnostic-related groups, for instance) with
the aim to close the gap between effectiveness and efficacy and,
at the same time, to obtain a global and integrated perspective
of the quality of health care delivered [26, 28].
The current study has contributed to demonstrate the
potential value of using a continuous national database, with
timely data analysis, for developing a risk-adjustment model
for major adverse cardiac and cerebrovascular events.
Perhaps the most significant limitation of the current study
is the lack of a systematic approach for auditing the data. In
our opinion, one of the bigger challenges for the future is the
need to submit all databases for a valid and objective audit
process, in order to guarantee the quality of the data.
With the proliferation of efforts to report publicly the out-
comes of healthcare providers and institutions, most of them
using risk-adjustment models, there was a growing need to
define standards for the methods that are being employed.
According to this, the interdisciplinary writing group for
quality of care and outcomes research of the American Heart
Association identified, recently, seven preferred attributes of
statistical models used [20].
It is our belief that this study includes all of the seven
attributes, namely, clear and explicit definition of an appro-
priate patient sample; clinical coherence of the model vari-
ables; sufficiently high-quality and timely data; designation of
an appropriate reference time before which covariates are
derived and after which outcomes are measured; use of an
adequate outcome and standardized period of outcome
assessment; application of an analytical approach that takes
into account the multilevel organization of data; and disclos-
ure of the methods used to compare outcomes, including
disclosure of performance of the risk-adjustment method-
ology in derivation and validation samples.
Nevertheless, the variables that were generated from our
model are consistent with a number of other studies recently
published [8, 9, 18, 29].
Conclusions
The risk-adjustment model developed in this study, by allow-
ing the identification and evaluation of patient risk factors
that are associated with poor outcomes or adverse events
represent a potential contribution to improve quality of care
through a more rigorous assessment of outcomes.
The variables that were generated from our model are
consistent with a number of other studies recently published.
These findings will likely represent a potential contribution
to improve quality and should help driving new research and
innovative approaches to different subgroups of patients who
have higher chances of having an adverse event or poorer
outcomes following PCI.
Despite the existence of models already described in the
literature, to our knowledge there is none based on data
from Euro Heart Survey database. This could be seen as an
effort to improve quality in a very relevant public health
burden disease, such as coronary artery disease.
In our opinion, this issue will be intensified in the years
ahead and should be studied more deeply because, on an
average, the occurrence of adverse events or poor results is
linked with an increase in financial and social costs.
Developing risk-adjustment models for major adverse
cardiac and cerebrovascular events following PCI is an
important part of the quality and safety improvement
process for cardiac revascularization procedures, and for
establishing credible and rigorous benchmarking values.
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